BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/12/2026 10:04:08 AM | Browse: 8 | Download: 2
Publication Name World Journal of Gastroenterology
Manuscript ID 126999
DOI 10.3748/wjg.126999
Country China
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Advances in the immunological basis and therapeutic strategies for functional cure of chronic hepatitis B
Manuscript Source Unsolicited Manuscript
All Author List Fan-E Cheng, Shi-Hao Zheng, Wen-Ying Qi, Xin-Yu Zhao, Chun-Feng Mei, Xiao-Bin Zao and Yong-An Ye
Funding Agency and Grant Number
Funding Agency Grant Number
Pilot Project for Enhancing Clinical Research and Technology Transfer Capabilities DZMG-XZYY-23003
Science, Technology and Innovation Specialization 2023 DZMKJCX-2023-014
Corresponding Author Yong-An Ye, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Haiyuncang Road, Dongcheng District, Beijing 100700, China. yeyonganvip@163.com
Key Words Chronic hepatitis B; Functional cure; Immune regulation; Immune exhaustion; Therapeutic strategies
Core Tip Functional cure of chronic hepatitis B is constrained by persistent viral reservoirs and sustained antigen-driven immune dysfunction. This dysfunction includes hepatitis B virus-specific T-cell exhaustion, B-cell dysfunction, hepatic immune tolerance, innate immune dysregulation, and metabolic and gut-liver axis remodeling. This review links these mechanisms to emerging therapies and outlines a staged strategy for durable HBsAg loss. Viral antigen reduction is followed by restoration of antiviral immunity using pegylated interferon, therapeutic vaccination, immune checkpoint modulation, or innate immune activation. Human clinical evidence has not yet established an optimal treatment sequence; biomarker-guided stratification and rational sequencing may help balance efficacy against immune-mediated liver injury.
Citation Cheng FE, Zheng SH, Qi WY, Zhao XY, Mei CF, Zao XB, Ye YA. Advances in the immunological basis and therapeutic strategies for functional cure of chronic hepatitis B. World J Gastroenterol 2026; In press
PDF 126999-in-press.pdf
Received
2026-08-19 02:53
Peer-Review Started
2026-08-19 02:53
First Decision by Editorial Office Director
Return for Revision
2026-09-02 06:16
Revised
2026-09-14 13:55
Publication Fee Transferred
2026-10-08 14:18
Second Decision by Editor
2026-11-12 06:05
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-12 10:04
Articles in Press
2026-11-12 10:04
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com